CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
<p>Abstract</p> <p>Background</p> <p>The CD44 cell adhesion molecule is aberrantly expressed in many breast tumors and has been implicated in the metastatic process as well as in the putative cancer stem cell (CSC) compartment. We aimed to investigate potential associat...
Main Authors: | Vallon-Christersson Johan, Ringnér Markus, Gruvberger-Saal Sofia, Saal Lao H, Bendahl Pär-Ola, Honeth Gabriella, Olsson Eleonor, Jönsson Göran, Holm Karolina, Lövgren Kristina, Fernö Mårten, Grabau Dorthe, Borg Åke, Hegardt Cecilia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/418 |
Similar Items
-
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
by: Eleonor Olsson, et al.
Published: (2015-01-01) -
Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.
by: Sara Alkner, et al.
Published: (2016-01-01) -
The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
by: Sara Jansson, et al.
Published: (2014-01-01) -
Refinement of breast cancer molecular classification by miRNA expression profiles
by: Rolf Søkilde, et al.
Published: (2019-06-01) -
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
by: Fernö Mårten, et al.
Published: (2011-03-01)